Go Pro

SAB Biotherapeutics (SABS) News Today

SAB Biotherapeutics logo
$3.41 -0.01 (-0.29%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.53 +0.12 (+3.52%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SAB Biotherapeutics Latest News

SAB BIO to Participate in Upcoming Investor Conferences
SAB Biotherapeutics advances SAB-142 Type 1 diabetes trial
SAB Biotherapeutics Inc SABS
SAB Biotherapeutics Signs Manufacturing Pact for SAB-142
SAB BIO to Participate in Upcoming Investor Conferences
SAB BIO to Participate in Upcoming Investor Conferences
SAB BIO to Participate in Upcoming Investor Conferences

SAB Biotherapeutics Media Mentions By Week

SAB Biotherapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SABS
News Sentiment

0.72

0.88

Average
Healthcare
News Sentiment

SAB Biotherapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SABS Articles
This Week

2

3

SABS Articles
Average Week

SAB Biotherapeutics Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
Page Views
2,077
-20%
Get SAB Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SABS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for SAB Biotherapeutics dated 9/10/2026.
From Our Partners